Search Results 1571-1580 of 14769 for anti-TNF drugs

  1. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) - Mayo Clinic

    ... treatment (including both insulin dependent and non-insulin dependent diabetes mellitus); Current or past use of insulin or any other anti-diabetic medication ...

  2. Sumatriptan (Nasal Route) Description and Brand Names - Mayo Clinic

    Sumatriptan works in the brain to relieve the pain from migraine headaches. It belongs to the group of medicines called triptans.

  3. Filgrastim-Sndz (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Filgrastim-sndz injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic ( ...

  4. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...

  5. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

    ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...

  6. Leflunomide (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Arava. Descriptions. Leflunomide is used to treat active ...

  7. Filgrastim-Aafi (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    When certain cancer medicines are used to fight cancer cells, they also affect the white blood cells that fight infections. Filgrastim-aafi is used to prevent ...

  8. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index - Mayo Clinic

    An algorithm for a CTC-Endocrine Therapy Index (CTC-ETI) has been constructed that can be calculated for each patient using the CTC enumeration and marker ...

  9. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

    * Prior treatment with any adoptive T-cell therapy or anti-ROR1 therapy * Prior solid organ transplantation * Active, untreated brain metastasis or ...

  10. Overview - Skeletal Development and Regeneration Research Laboratory - Mayo Clinic Research

    D., of Mayo Clinic, and a. Validating new treatment targets. Work in our lab is revealing novel insights into numerous musculoskeletal diseases, with a goal of ...